We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Women should avoid pregnancy for six months after ending treatment with certain anticancer drugs to keep the drugs from harming an embryo or fetus, the FDA recommended in draft guidance. Read More
Manufacturers of short-acting opioids will be required to offer the kind of doctor training in administering the medications that their extended-release counterparts have been directed to provide since 2012, FDA Commissioner Scott Gottlieb said. Read More